/

Korro Bio

Develops RNA editing medicines for rare and prevalent diseases.

BiotechnologyPharmaceuticals korrobio.com ↗

Company facts

Founded: 2018
Employees: 87
Headquarters: United States
Type: Public
Listed: NASDAQ: KRRO